The
cardioplegia solution was administered to arrest the patient's heart during surgery.
这个心肌松弛液在手术中被用来使患者的心脏停止跳动。
The cardiologist carefully monitored the effectiveness of the
cardioplegia during the procedure.
心脏外科医生密切监控了心脏停搏液在手术过程中的效果。
The patient experienced some temporary cardiac dysfunction after the
cardioplegia, but it resolved quickly.
患者在使用了心脏停搏液后出现了一时的心脏功能障碍,但很快就恢复了。
The anesthesiologist injected a new type of
cardioplegia that promised less damage to the heart tissue.
麻醉师注入了一种新型心脏停搏液,据说能减少对心脏组织的损害。
Cardioplegia is crucial in preventing reperfusion injury during heart bypass surgery.
在心脏搭桥手术中,心脏停搏液对于防止再灌注损伤至关重要。
The surgeon needed to administer a second dose of
cardioplegia as the first one had worn off.
因为第一次的心脏停搏液效果减弱,外科医生需要再次给予。
Postoperative care for patients who received
cardioplegia involves close monitoring of their cardiac function.
接受心脏停搏液的患者的术后护理需要密切关注他们的心脏功能。
During open-heart surgery,
cardioplegia is used to maintain complete cardiac arrest for extended periods.
开胸手术期间,心脏停搏液用于维持长时间完全的心脏停搏状态。
Cardioplegic solutions often contain potassium to achieve the desired effect on cardiac muscle relaxation.
心脏停搏液通常含有钾,以达到使心脏肌肉放松的效果。
Advances in
cardioplegia research aim to minimize blood loss and improve patient outcomes during cardiac procedures.
心脏停搏液研究的进展旨在减少失血并改善心脏手术患者的治疗结果。
未经许可,严禁转发。QQ交流群:688169419